210 related articles for article (PubMed ID: 16304159)
1. Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus.
Zhu W; Burnette A; Dorjsuren D; Roberts PE; Huleihel M; Shoemaker RH; Marquez VE; Agbaria R; Sei S
Antimicrob Agents Chemother; 2005 Dec; 49(12):4965-73. PubMed ID: 16304159
[TBL] [Abstract][Full Text] [Related]
2. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Medveczky MM; Horvath E; Lund T; Medveczky PG
AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
[TBL] [Abstract][Full Text] [Related]
3. Metabolic pathways of N-methanocarbathymidine, a novel antiviral agent, in native and herpes simplex virus type 1 infected Vero cells.
Zalah L; Huleihel M; Manor E; Konson A; Ford H; Marquez VE; Johns DG; Agbaria R
Antiviral Res; 2002 Jul; 55(1):63-75. PubMed ID: 12076752
[TBL] [Abstract][Full Text] [Related]
4. The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent.
Marquez VE; Hughes SH; Sei S; Agbaria R
Antiviral Res; 2006 Sep; 71(2-3):268-75. PubMed ID: 16730077
[TBL] [Abstract][Full Text] [Related]
5. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
[TBL] [Abstract][Full Text] [Related]
6. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and metabolic activation of N-methanocarbathymidine, a novel thymidine analogue with a pseudosugar rigidly fixed in the northern conformation, in murine colon cancer cells expressing herpes simplex thymidine kinase.
Noy R; Ben-Zvi Z; Manor E; Candotti F; Morris JC; Ford H; Marquez VE; Johns DG; Agbaria R
Mol Cancer Ther; 2002 Jun; 1(8):585-93. PubMed ID: 12479218
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Kedes DH; Ganem D
J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis.
Chen J; Zhang H; Chen X
Antiviral Res; 2020 Aug; 180():104825. PubMed ID: 32461120
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and structural characterization of (South)-methanocarbathymidine that specifically inhibits growth of herpes simplex virus type 1 thymidine kinase-transduced osteosarcoma cells.
Schelling P; Claus MT; Johner R; Marquez VE; Schulz GE; Scapozza L
J Biol Chem; 2004 Jul; 279(31):32832-8. PubMed ID: 15163659
[TBL] [Abstract][Full Text] [Related]
11. Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis.
Dorjsuren D; Burnette A; Gray GN; Chen X; Zhu W; Roberts PE; Currens MJ; Shoemaker RH; Ricciardi RP; Sei S
Antiviral Res; 2006 Jan; 69(1):9-23. PubMed ID: 16337284
[TBL] [Abstract][Full Text] [Related]
12. An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.
Dubich T; Lieske A; Santag S; Beauclair G; Rückert J; Herrmann J; Gorges J; Büsche G; Kazmaier U; Hauser H; Stadler M; Schulz TF; Wirth D
J Mol Med (Berl); 2019 Mar; 97(3):311-324. PubMed ID: 30610257
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
Cheng F; He M; Jung JU; Lu C; Gao SJ
J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
[TBL] [Abstract][Full Text] [Related]
15. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II.
Xu B; Wang L; González-Molleda L; Wang Y; Xu J; Yuan Y
Antimicrob Agents Chemother; 2014; 58(1):563-73. PubMed ID: 24295975
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
Yang M; Huang L; Li X; Kuang E
Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
[TBL] [Abstract][Full Text] [Related]
18. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
19. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.
Uppal T; Meyer D; Agarwal A; Verma SC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
